Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMC 268086)

Published in J Clin Microbiol on September 01, 1990

Authors

M Yamamoto1, J B Black, J A Stewart, C Lopez, P E Pellett

Author Affiliations

1: Division of Viral and Rickettsial Diseases, Centers for Disease Control, Atlanta, Georgia 30333.

Articles citing this

Human herpesvirus 7: antigenic properties and prevalence in children and adults. J Virol (1991) 1.93

Human herpesvirus 6. Clin Microbiol Rev (1997) 1.91

Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol (2000) 1.41

Nucleotide sequence analysis of a 38.5-kilobase-pair region of the genome of human herpesvirus 6 encoding human cytomegalovirus immediate-early gene homologs and transactivating functions. J Virol (1994) 1.33

Human herpesvirus 6: An emerging pathogen. Emerg Infect Dis (1999) 1.33

Temporal mapping of transcripts in herpesvirus 6 variants. J Virol (1998) 1.24

The BFRF1 gene of Epstein-Barr virus encodes a novel protein. J Virol (2000) 1.20

Human herpesvirus 6 latently infects early bone marrow progenitors in vivo. J Virol (1999) 1.08

Gene for the major antigenic structural protein (p100) of human herpesvirus 6. J Virol (1992) 1.05

Human herpesvirus 8--a novel human pathogen. Virol J (2005) 1.00

The 85-kilodalton phosphoprotein (pp85) of human herpesvirus 7 is encoded by open reading frame U14 and localizes to a tegument substructure in virion particles. J Virol (1997) 0.99

Evaluation of immunoassays for detection of antibodies to human herpesvirus 7. Clin Diagn Lab Immunol (1996) 0.99

Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J Virol (2002) 0.84

Development of recombinant diagnostic reagents based on pp85(U14) and p86(U11) proteins to detect the human immune response to human herpesvirus 7 infection. J Clin Microbiol (1999) 0.82

No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome. Am J Transl Res (2012) 0.80

Development of a human herpesvirus 6 species-specific immunoblotting assay. J Clin Microbiol (2012) 0.80

An immunoblot assay for detection of immunoglobulin M antibody to human herpesvirus 6. Clin Diagn Lab Immunol (2000) 0.79

Comparison of specific serological assays for diagnosing human herpesvirus 6 infection after liver transplantation. Clin Diagn Lab Immunol (2001) 0.78

Immune response to HHV-6 and implications for immunotherapy. Curr Opin Virol (2014) 0.78

Crystal Structure of Human Herpesvirus 6B Tegument Protein U14. PLoS Pathog (2016) 0.75

Articles cited by this

Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion. J Virol (1972) 17.28

Anatomy of herpes simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 X HSV-2 recombinants. J Virol (1978) 11.19

Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet (1988) 8.76

A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth. Cell (1981) 8.56

Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science (1986) 8.15

Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA (1988) 3.89

Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus. J Virol (1976) 3.83

Isolation of human lymphotropic herpesviruses from Uganda. Lancet (1987) 3.26

Characteristics of human herpesvirus-6. J Infect Dis (1988) 3.02

Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase. J Gen Virol (1989) 3.01

A novel lymphotropic herpesvirus. Lancet (1987) 2.89

Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol (1989) 2.58

Human herpesvirus 6 is closely related to human cytomegalovirus. J Virol (1990) 2.34

The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties. J Gen Virol (1987) 2.13

Unity and diversity in the herpesviruses. J Gen Virol (1977) 2.11

DNA homology between a novel human herpesvirus (HHV-6) and human cytomegalovirus. Lancet (1988) 1.94

Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes. Hybridoma (1984) 1.67

Age prevalence of antibody to human herpesvirus 6. Lancet (1988) 1.66

Antibody reactivity with HBLV (HHV-6) in U.S. populations. J Virol Methods (1988) 1.65

Identification of proteins specific for human herpesvirus 6-infected human T cells. J Virol (1989) 1.60

Human B-lymphotropic virus (human herpesvirus-6). J Virol Methods (1988) 1.48

Comparative analyses of the proteins and antigens of five herpesviruses. J Gen Virol (1977) 1.33

Molecular studies of HHV-6. J Virol Methods (1988) 1.32

Growth properties of human herpesvirus-6 strain Z29. J Virol Methods (1989) 1.23

Relative titers of antibodies to individual polypeptide antigens of herpes simplex virus type 1 in human sera. J Infect Dis (1983) 1.21

IgG antibodies to human herpesvirus-6 in children and adults and in primary Epstein-Barr virus infections and cytomegalovirus infections [corrected]. J Virol Methods (1988) 1.20

Identification, cloning, and expression of the major capsid protein gene of human herpesvirus 6. J Virol (1990) 1.19

High prevalence of antibody to human herpesvirus-6 and seroconversion associated with rash in two infants. Lancet (1988) 1.12

Fall in human herpesvirus 6 seropositivity with age. Lancet (1988) 1.09

Human herpesvirus-6 and cross-reactivity with other herpesviruses. Lancet (1989) 0.86

Virion and nonstructural polypeptides of human herpesvirus-6. Virus Res (1989) 0.81

Immune response of patients with exanthema subitum to human herpesvirus type 6 (HHV-6) polypeptides. J Infect Dis (1989) 0.78

Articles by these authors

Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54

Rubella hemagglutinin prepared with alkaline extraction of virus grown in suspension culture of BHK-21 cells. Proc Soc Exp Biol Med (1967) 5.61

Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med (1981) 5.44

Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol (1996) 5.05

Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA (1988) 3.89

Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77

Nucleotide sequence and predicted amino acid sequence of a protein encoded in a small herpes simplex virus DNA fragment capable of trans-inducing alpha genes. Proc Natl Acad Sci U S A (1985) 3.75

Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistant mutants. J Virol (1985) 3.67

Isolation and identification of Haemophilus ducreyi in a clinical study. J Clin Microbiol (1980) 3.40

Genetics of natural resistance to herpesvirus infections in mice. Nature (1975) 3.18

The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses. Arch Virol (1992) 3.09

Rubella hemagglutinin prepared in serum free suspension culture of BHK-21 cells. Ann Med Exp Biol Fenn (1967) 2.89

Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides. J Med Chem (1979) 2.80

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. Neurology (2006) 2.75

Mutations affecting conformation or sequence of neutralizing epitopes identified by reactivity of viable plaques segregate from syn and ts domains of HSV-1(F) gB gene. Virology (1984) 2.44

The microbiological flora of penile ulcerations. J Infect Dis (1978) 2.43

Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol (1999) 2.42

Primary human herpesvirus 6 infection in young children. N Engl J Med (1992) 2.30

Indirect hemagglutination test for detection of antibodies to Cytomegalovirus. Appl Microbiol (1971) 2.28

Epstein-Barr virus genome may encode a protein showing significant amino acid and predicted secondary structure homology with glycoprotein B of herpes simplex virus 1. J Virol (1985) 2.25

A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study. Diabet Med (2006) 2.15

Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%. Am J Ophthalmol (2001) 2.06

Multidisciplinary approach to deep-seated lesions requiring radiologically-guided fine-needle aspiration. Diagn Cytopathol (1998) 2.04

Cytomegalovirus specific IgM and IgG response in humans studied by radioimmunoassay. J Immunol (1976) 2.03

2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent. Antimicrob Agents Chemother (1980) 1.96

Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody. Infect Immun (1979) 1.94

Human herpesvirus 6. Clin Microbiol Rev (1997) 1.91

Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83

Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83

Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med (1975) 1.80

A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA (1987) 1.75

Method for typing antisera to Herpesvirus hominis by indirect hemagglutination inhibition. Appl Microbiol (1971) 1.70

How reliable is the morphological diagnosis of penile ulcerations? Sex Transm Dis (1978) 1.70

Transcription initiation sites and nucleotide sequence of a herpes simplex virus 1 gene conserved in the Epstein-Barr virus genome and reported to affect the transport of viral glycoproteins. J Virol (1986) 1.68

Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol (1991) 1.68

Characterization of a new primary human pancreatic tumor line. Cancer Invest (1986) 1.67

Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases. Ann Intern Med (1973) 1.65

Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293. Med Oncol (1996) 1.65

Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis (1995) 1.60

Combined doppler and phased-array echocardiographic estimation of cardiac output. Circulation (1981) 1.57

Untreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometry. Eye (Lond) (2009) 1.57

Characterization and nucleotide sequence of two herpes simplex virus 1 genes whose products modulate alpha-trans-inducing factor-dependent activation of alpha genes. J Virol (1987) 1.57

Transactivation of human immunodeficiency virus by herpesviruses. Oncogene (1987) 1.57

Experimental alveolar lipo-proteinosis following the inhalation of silica. J Pathol (1970) 1.56

Cell-mediated immune responses in recurrent herpesvirus infections. I. Lymphocyte proliferation assay. J Immunol (1977) 1.51

Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis (1991) 1.50

Rubella complement fixing antigen prepared by alkaline extraction of virus grown in suspension culture of BHK-211 cells. Proc Soc Exp Biol Med (1967) 1.49

The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia (1984) 1.48

Doctors who do not feel sober enough to drive should avoid helping in medical emergencies. BMJ (1998) 1.47

Toward an ecosocial view of health. Int J Health Serv (1999) 1.47

Accuracy of magnetic resonance imaging of inguinofemoral lymph nodes in vulval cancer. Int J Gynecol Cancer (2006) 1.47

Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax (1994) 1.46

Isolation of a virus from the lungs of Montana sheep affected with progressive pneumonia. Virology (1968) 1.46

Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins. Blood (2001) 1.45

Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology (1986) 1.43

Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model. Eye (Lond) (2007) 1.43

Detection of persistent left superior vena cava by two-dimensional contrast echocardiography. J Clin Ultrasound (1979) 1.42

Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol (2000) 1.41

Mammography after treatment for breast cancer. BMJ (1994) 1.40

Cerebrovascular risk factors and stroke subtypes: differences between ethnic groups. Stroke (2001) 1.39

Beyond code teams: early defibrillation by nurses for in-hospital cardiac arrests. J Emerg Nurs (1992) 1.39

Optimizing "delay period" for burst stimulation in dynamic cardiomyoplasty. Ann Thorac Surg (1995) 1.38

Histology and prevalence of ovarian tumours in postmenopausal women: is follow-up required in all cases? J Obstet Gynaecol (2012) 1.38

Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets. J Immunol (1983) 1.37

Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J Gen Virol (1999) 1.37

Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg (1974) 1.34

Echocardiographic documentation of vegetative lesions in infective endocarditis: clinical implications. Circulation (1980) 1.32

Individuals from North America, Australasia, and Africa are infected with four different genotypes of human herpesvirus 8. Virology (1999) 1.32

Cytomegalovirus mononucleosis in a first trimester pregnant female with transmission to the fetus. Pediatrics (1971) 1.31

1,000 consecutive ultrasounds for blunt abdominal trauma. J Trauma (1996) 1.31

Facilitation or attenuation of mixed leukocyte culture responsiveness by adherent cells. Nature (1976) 1.31

Evaluation of serological techniques for titration of rubella antibody. Am J Public Health Nations Health (1969) 1.29

A strongly immunoreactive virion protein of human herpesvirus 6 variant B strain Z29: identification and characterization of the gene and mapping of a variant-specific monoclonal antibody reactive epitope. Virology (1993) 1.27

Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis. J Immunol (1977) 1.27

The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye (Lond) (2006) 1.26

Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection. Hepatology (1998) 1.26

Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol (1998) 1.25

Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993. MMWR CDC Surveill Summ (1997) 1.25

Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients. JAMA (1978) 1.24

High-level transient expression of influenza virus proteins from a series of SV40 late and early replacement vectors. Gene (1988) 1.24

Glycoprotein B of human herpesvirus 8 is a component of the virion in a cleaved form composed of amino- and carboxyl-terminal fragments. Virology (2000) 1.24

Role of virus infections in immunosuppressed renal transplant patients. Transplant Proc (1973) 1.23

The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia. J Neurovirol (1998) 1.23

Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity. J Clin Invest (1986) 1.23

Fracture of the outlet strut of a Björk-Shiley mitral prosthesis: emergency operation with survival. J Thorac Cardiovasc Surg (1984) 1.23

Growth properties of human herpesvirus-6 strain Z29. J Virol Methods (1989) 1.23

Identification of a lytic-phase origin of DNA replication in human herpesvirus 6B strain Z29. J Virol (1993) 1.23

Role of interferon in natural kill of HSV-1-infected fibroblasts. J Immunol (1982) 1.22

Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol (1999) 1.22

Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen. J Clin Microbiol (1999) 1.22

Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J (1991) 1.20

Correlation between low natural killing of fibroblasts infected with herpes simplex virus type 1 and susceptibility to herpesvirus infections. J Infect Dis (1983) 1.19

Properties of the human herpesvirus 6 strain Z29 genome: G + C content, length, and presence of variable-length directly repeated terminal sequence elements. Virology (1991) 1.18

Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands. JAMA (1988) 1.18

Guidelines for the prevention and treatment of B-virus infections in exposed persons. The B virus Working Group. Clin Infect Dis (1995) 1.18